172 related articles for article (PubMed ID: 23724033)
41. A real-time fluorescent assay of the purified nitric oxide receptor, guanylyl cyclase.
Newton M; Niewczas I; Clark J; Bellamy TC
Anal Biochem; 2010 Jul; 402(2):129-36. PubMed ID: 20371357
[TBL] [Abstract][Full Text] [Related]
42. Interstitial cells of Cajal contain signalling molecules for transduction of nitrergic stimulation in guinea pig caecum.
Iino S; Horiguchi K; Nojyo Y; Ward SM; Sanders KM
Neurogastroenterol Motil; 2009 May; 21(5):542-50, e12-3. PubMed ID: 19175750
[TBL] [Abstract][Full Text] [Related]
43. Hypoxia induces downregulation of soluble guanylyl cyclase β1 by miR-34c-5p.
Xu X; Wang S; Liu J; Dou D; Liu L; Chen Z; Ye L; Liu H; He Q; Raj JU; Gao Y
J Cell Sci; 2012 Dec; 125(Pt 24):6117-26. PubMed ID: 23038777
[TBL] [Abstract][Full Text] [Related]
44. The expression of soluble guanylate cyclase in the vasculature of rat skeletal muscle.
Fukutani T; Iino S; Nojyo Y
Arch Histol Cytol; 2009 Jul; 72(2):117-26. PubMed ID: 20009348
[TBL] [Abstract][Full Text] [Related]
45. The soluble guanylyl cyclase inhibitor NS-2028 reduces vascular endothelial growth factor-induced angiogenesis and permeability.
Morbidelli L; Pyriochou A; Filippi S; Vasileiadis I; Roussos C; Zhou Z; Loutrari H; Waltenberger J; Stössel A; Giannis A; Ziche M; Papapetropoulos A
Am J Physiol Regul Integr Comp Physiol; 2010 Mar; 298(3):R824-32. PubMed ID: 20032260
[TBL] [Abstract][Full Text] [Related]
46. Regulation of nitric oxide and soluble guanylyl cyclase.
Krumenacker JS; Hanafy KA; Murad F
Brain Res Bull; 2004 Feb; 62(6):505-15. PubMed ID: 15036565
[TBL] [Abstract][Full Text] [Related]
47. Soluble guanylyl cyclase α1 subunit is a key mediator of proliferation, survival, and migration in ECC-1 and HeLa cell lines.
Ronchetti SA; Pino MTL; Cordeiro G; Bollani SN; Ricci AG; Duvilanski BH; Cabilla JP
Sci Rep; 2019 Oct; 9(1):14797. PubMed ID: 31616026
[TBL] [Abstract][Full Text] [Related]
48. Decreased Soluble Guanylate Cyclase Contributes to Cardiac Dysfunction Induced by Chronic Doxorubicin Treatment in Mice.
Vandenwijngaert S; Swinnen M; Walravens AS; Beerens M; Gillijns H; Caluwé E; Tainsh RE; Nathan DI; Allen K; Brouckaert P; Bartunek J; Scherrer-Crosbie M; Bloch KD; Bloch DB; Janssens SP; Buys ES
Antioxid Redox Signal; 2017 Feb; 26(4):153-164. PubMed ID: 27505125
[TBL] [Abstract][Full Text] [Related]
49. The alpha2beta1 isoform of guanylyl cyclase mediates plasma membrane localized nitric oxide signalling.
Bellingham M; Evans TJ
Cell Signal; 2007 Oct; 19(10):2183-93. PubMed ID: 17643962
[TBL] [Abstract][Full Text] [Related]
50. Nitric oxide receptor soluble guanylyl cyclase undergoes splicing regulation in differentiating human embryonic cells.
Sharin VG; Mujoo K; Kots AY; Martin E; Murad F; Sharina IG
Stem Cells Dev; 2011 Jul; 20(7):1287-93. PubMed ID: 20964618
[TBL] [Abstract][Full Text] [Related]
51. Regulation of soluble guanylyl cyclase activity by oestradiol and progesterone in the hypothalamus but not hippocampus of female rats.
Reyna-Neyra A; Sarkar G; Etgen AM
J Neuroendocrinol; 2007 Jun; 19(6):418-25. PubMed ID: 17388815
[TBL] [Abstract][Full Text] [Related]
52. Stimulation of soluble guanylate cyclase slows progression in anti-thy1-induced chronic glomerulosclerosis.
Wang Y; Krämer S; Loof T; Martini S; Kron S; Kawachi H; Shimizu F; Neumayer HH; Peters H
Kidney Int; 2005 Jul; 68(1):47-61. PubMed ID: 15954895
[TBL] [Abstract][Full Text] [Related]
53. Regional and age-dependent expression of the nitric oxide receptor, soluble guanylyl cyclase, in the human brain.
Ibarra C; Nedvetsky PI; Gerlach M; Riederer P; Schmidt HH
Brain Res; 2001 Jul; 907(1-2):54-60. PubMed ID: 11430885
[TBL] [Abstract][Full Text] [Related]
54. [Nitric oxide. Potentiation of NO-dependent activation of soluble guanylate cyclase--(patho)physiological and pharmacotherapeutical significance].
Severina IS
Biomed Khim; 2007; 53(4):385-99. PubMed ID: 18035720
[TBL] [Abstract][Full Text] [Related]
55. Prolonged therapy with the soluble guanylyl cyclase activator BAY 60-2770 restores the erectile function in obese mice.
Silva FH; Leiria LO; Alexandre EC; Davel AP; Mónica FZ; De Nucci G; Antunes E
J Sex Med; 2014 Nov; 11(11):2661-70. PubMed ID: 25196910
[TBL] [Abstract][Full Text] [Related]
56. The chemistry and biology of soluble guanylate cyclase stimulators and activators.
Follmann M; Griebenow N; Hahn MG; Hartung I; Mais FJ; Mittendorf J; Schäfer M; Schirok H; Stasch JP; Stoll F; Straub A
Angew Chem Int Ed Engl; 2013 Sep; 52(36):9442-62. PubMed ID: 23963798
[TBL] [Abstract][Full Text] [Related]
57. Thrombospondin-1 and angiotensin II inhibit soluble guanylyl cyclase through an increase in intracellular calcium concentration.
Ramanathan S; Mazzalupo S; Boitano S; Montfort WR
Biochemistry; 2011 Sep; 50(36):7787-99. PubMed ID: 21823650
[TBL] [Abstract][Full Text] [Related]
58. The receptor-like properties of nitric oxide-activated soluble guanylyl cyclase in intact cells.
Bellamy TC; Garthwaite J
Mol Cell Biochem; 2002 Jan; 230(1-2):165-76. PubMed ID: 11952092
[TBL] [Abstract][Full Text] [Related]
59. Androgen-sensitive hypertension associated with soluble guanylate cyclase-α1 deficiency is mediated by 20-HETE.
Dordea AC; Vandenwijngaert S; Garcia V; Tainsh RE; Nathan DI; Allen K; Raher MJ; Tainsh LT; Zhang F; Lieb WS; Mikelman S; Kirby A; Stevens C; Thoonen R; Hindle AG; Sips PY; Falck JR; Daly MJ; Brouckaert P; Bloch KD; Bloch DB; Malhotra R; Schwartzman ML; Buys ES
Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1790-800. PubMed ID: 27199131
[TBL] [Abstract][Full Text] [Related]
60. Pressure-overload-induced subcellular relocalization/oxidation of soluble guanylyl cyclase in the heart modulates enzyme stimulation.
Tsai EJ; Liu Y; Koitabashi N; Bedja D; Danner T; Jasmin JF; Lisanti MP; Friebe A; Takimoto E; Kass DA
Circ Res; 2012 Jan; 110(2):295-303. PubMed ID: 22095726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
